BlackRock’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $7.22M | Buy |
|
|||||
|
2022
Q3 | $5.54M | Buy |
|
|||||
|
2022
Q2 | $1.83M | Sell |
|
|||||
|
2022
Q1 | $1.51M | Sell |
|
|||||
|
2021
Q4 | $1.42M | Sell |
|
|||||
|
2021
Q3 | $2.35M | Buy |
|
|||||
|
2021
Q2 | $2.83M | Sell |
|
|||||
|
2021
Q1 | $11.6M | Buy |
|
|||||
|
2020
Q4 | $27.9M | Buy |
|
|||||
|
2020
Q3 | $17.8M | Sell |
|
|||||
|
2020
Q2 | $18.1M | Buy |
|
|||||
|
2020
Q1 | $15.5M | Buy |
|
|||||
|
2019
Q4 | $13.9M | Sell |
|
|||||
|
2019
Q3 | $10.2M | Buy |
|
|||||
|
2019
Q2 | $20.4M | Sell |
|
|||||
|
2019
Q1 | $20.8M | Buy |
|
|||||
|
2018
Q4 | $21.3M | Buy |
|
|||||
|
2018
Q3 | $24.9M | Buy |
|
|||||
|
2018
Q2 | $27.6M | Buy |
|
|||||
|
2018
Q1 | $36.5M | Sell |
|
|||||
|
2017
Q4 | $46.2M | Buy |
|
|||||
|
2017
Q3 | $16.8M | Buy |
|
|||||
|
2017
Q2 | $15.5M | Sell |
|
|||||
|
2017
Q1 | $19M | Buy |
|
|||||
|
2016
Q4 | $26K | Sell |
|
|||||
|
2016
Q3 | $28K | Buy |
|
|||||
|
2016
Q2 | $27K | Buy |
|
|||||
|
2016
Q1 | $16K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $8K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $145K | Sell |
|
|||||
|
2014
Q3 | $296K | Sell |
|
|||||
|
2014
Q2 | $489K | Hold |
|
|||||
|
2014
Q1 | $651K | Buy |
|